These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
677 related articles for article (PubMed ID: 182896)
1. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental automimmune myasthenia gravis. Lindstrom JM; Einarson BL; Lennon VA; Seybold ME J Exp Med; 1976 Sep; 144(3):726-38. PubMed ID: 182896 [TBL] [Abstract][Full Text] [Related]
2. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine recepotr antibodies. Lindstrom JM; Engel AG; Seybold ME; Lennon VA; Lambert EH J Exp Med; 1976 Sep; 144(3):739-53. PubMed ID: 182897 [TBL] [Abstract][Full Text] [Related]
3. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis. Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231 [TBL] [Abstract][Full Text] [Related]
4. Experimental autoimmune myasthenia: A model of myasthenia gravis in rats and guinea pigs. Lennon VA; Lindstrom JM; Seybold ME J Exp Med; 1975 Jun; 141(6):1365-75. PubMed ID: 1127382 [TBL] [Abstract][Full Text] [Related]
5. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis. Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851 [TBL] [Abstract][Full Text] [Related]
6. Neuromuscular Transmission in experimental autoimmune myasthenia gravis (EAMG). Quantitative ionophoresis and current fluctuation analysis at normal and myasthenic rat end-plates. Hohlfeld R; Sterz R; Kalies I; Peper K; Wekerle H Pflugers Arch; 1981 May; 390(2):156-60. PubMed ID: 6264388 [TBL] [Abstract][Full Text] [Related]
7. Role of acetylcholine receptor antibody complexes in muscle in experimental autoimmune myasthenia gravis. Verschuuren JJ; Graus YM; Theunissen RO; Yamamoto T; Vincent A; van Breda Vriesman PJ; De Baets MH J Neuroimmunol; 1992 Feb; 36(2-3):117-25. PubMed ID: 1732277 [TBL] [Abstract][Full Text] [Related]
8. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acetylcholine receptor-antibody complexes. Biesecker G; Koffler D J Immunol; 1988 May; 140(10):3406-10. PubMed ID: 3258882 [TBL] [Abstract][Full Text] [Related]
11. In vitro quantitative autoradiography of [125I]alpha-bungarotoxin binding at the motor end-plates of experimental autoimmune myasthenia gravis. Motomura M; Niwa M; Kataoka Y; Ootsuru I; Yoshimura T; Tsujihata M; Nagataki S Neurosci Lett; 1992 Aug; 143(1-2):139-42. PubMed ID: 1436658 [TBL] [Abstract][Full Text] [Related]
12. Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis. De Baets MH; Verschuuren J; Daha MR; van Breda Vriesman PJ Immunol Res; 1988; 7(3):200-11. PubMed ID: 3264006 [TBL] [Abstract][Full Text] [Related]
13. Monoclonal autoantibodies to acetylcholine receptors: evidence for a dominant idiotype and requirement of complement for pathogenicity. Lennon VA; Lambert EH Ann N Y Acad Sci; 1981; 377():77-96. PubMed ID: 6176167 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of rapsyn in rat muscle increases acetylcholine receptor levels in chronic experimental autoimmune myasthenia gravis. Martínez-Martínez P; Losen M; Duimel H; Frederik P; Spaans F; Molenaar P; Vincent A; De Baets MH Am J Pathol; 2007 Feb; 170(2):644-57. PubMed ID: 17255332 [TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Lindstrom JM; Lennon VA; Seybold ME; Whittingham S Ann N Y Acad Sci; 1976; 274():254-74. PubMed ID: 1066988 [TBL] [Abstract][Full Text] [Related]
16. Age-related resistance to experimental autoimmune myasthenia gravis in rats. Graus YM; Verschuuren JJ; Spaans F; Jennekens F; van Breda Vriesman PJ; De Baets MH J Immunol; 1993 May; 150(9):4093-103. PubMed ID: 8386206 [TBL] [Abstract][Full Text] [Related]
17. Passive transfer of experimental autoimmune myasthenia gravis by monoclonal antibodies to the main immunogenic region of the acetylcholine receptor. Tzartos S; Hochschwender S; Vasquez P; Lindstrom J J Neuroimmunol; 1987 Jun; 15(2):185-94. PubMed ID: 3495549 [TBL] [Abstract][Full Text] [Related]
18. Standardization of the experimental autoimmune myasthenia gravis (EAMG) model by immunization of rats with Torpedo californica acetylcholine receptors--Recommendations for methods and experimental designs. Losen M; Martinez-Martinez P; Molenaar PC; Lazaridis K; Tzartos S; Brenner T; Duan RS; Luo J; Lindstrom J; Kusner L Exp Neurol; 2015 Aug; 270():18-28. PubMed ID: 25796590 [TBL] [Abstract][Full Text] [Related]
19. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Krolick KA; Yeh TM; Edlund SA Cell Immunol; 1996 Aug; 172(1):10-20. PubMed ID: 8806801 [TBL] [Abstract][Full Text] [Related]
20. Acetylcholine receptor and thymus in experimental autoimmune myasthenia gravis and experimental myositis. Ueno S; Wada K; Kang J; Takahashi M; Tarui S Clin Exp Immunol; 1982 Dec; 50(3):563-71. PubMed ID: 7165999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]